Professor Anas Younes is a University Professor at the Weill-Cornell Medical College, and the acting Chief of Lymphoma Service at the Memorial Sloan Kettering Cancer Center.
Educated at The University of Damascus School of Medicine (Damascus, Syria), Prof. Younes then went on to take his residencies at firstly the Medical College of Ohio (Toledo, Ohio) and then on to complete his internal medicine residency at the SUNY Downstate Medical Center (Brooklyn, NY). He then made the short move over to the Memorial Sloan Kettering Cancer Center (New York, NY) to complete his hematology-oncology fellowship.
Following his fellowship, in 1992 Prof. Younes moved over to the M.D. Anderson Cancer Centre (Houston, Texas) where he carried out a lot of research and treatment for the next two decades. Then in 2013, Prof. Younes made the move back east to become the Chief of Lymphoma Service at the Memorial Sloan Kettering Cancer Center (New York, NY).
With particular interest in both Non-Hodgkin and Hodgkin Lymphoma, Prof. Younes works closely with the development of novel targeted therapies for lymphoma, as well as the identification of biomarkers for treatment. He has been the principal investigator in over 60 clinical trials, including some of the pivotal trials around nivolumab and brentuximab vedotin in relapse/refractory Hodgkin Lymphoma; which resulted in FDA approvals.
Positions of responsibility/awards:
- Member of the Scientific Advisory Board of the Lymphoma Research Foundation
- Past Member of the National Cancer Institute Lymphoma Steering Committee
- Leader of the National Cancer Institute – funded SPORE (Specialized Programs of Research Excellence) in lymphoma bot at MDACC (MD Anderson Cancer Center) and MSKCC (Memorial Sloan Kettering Cancer Center)
- Principal Investigator of a SCOR grant supported by the Leukemia and Lymphoma Society
Prof. Anas Younes is also a highly active participant on Twitter, you can follow him on his handle - @DrAnasYounes